Bausch Health
BHC
#4242
Rank
โ‚น227.84 B
Marketcap
โ‚น614.21
Share price
-1.59%
Change (1 day)
-5.82%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2025 (TTM): โ‚น84.70

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is โ‚น87.36. In 2024 the company made an earnings per share (EPS) of -โ‚น10.81 an increase over its 2023 EPS that were of -โ‚น145.90.

EPS history for Bausch Health from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น84.70-883.74%
2024-โ‚น10.81-92.59%
2023-โ‚น145.90160.89%
2022-โ‚น55.92-76.64%
2021-โ‚น239.3868.45%
2020-โ‚น142.10-68.91%
2019-โ‚น457.05-57.11%
2018-โ‚น1,066-272.22%
2017โ‚น618.82-199.29%
2016-โ‚น623.22798.7%
2015-โ‚น69.35-128.31%
2014โ‚น244.96-204.62%
2013-โ‚น234.16602.7%
2012-โ‚น33.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น85.56-197.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น21.61-124.74%๐Ÿ‡บ๐Ÿ‡ธ USA